UTS2R and persistent truncus arteriosus: However, GPR14 expression was significantly upregulated in 0.2% DS37001789-treated TAC left ventricles (vehicle-treated TAC vs. 0.2% DS37001789-treated TAC: 1.6 ± 0.1 vs. 4.3 ± 0.1, P < 0.05).